Related references
Note: Only part of the references are listed.Fine-needle aspiration biopsy of pancreatic neuroendocrine tumors: Correlation between Ki-67 index in cytological samples and clinical behavior
Cristina Diaz del Arco et al.
DIAGNOSTIC CYTOPATHOLOGY (2017)
CpG methylation of ubiquitin carboxyl-terminal hydrolase 1 (UCHL1) and P53 mutation pattern in sporadic colorectal cancer
Rania Abdelmaksoud-Dammak et al.
TUMOR BIOLOGY (2016)
Long-term acquired everolimus resistance in pancreatic neuroendocrine tumours can be overcome with novel PI3K-AKT-mTOR inhibitors
Timon Vandamme et al.
BRITISH JOURNAL OF CANCER (2016)
Whole-exome characterization of pancreatic neuroendocrine tumor cell lines BON-1 and QGP-1
Timon Vandamme et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2015)
limma powers differential expression analyses for RNA-sequencing and microarray studies
Matthew E. Ritchie et al.
NUCLEIC ACIDS RESEARCH (2015)
A novel recurrent CHEK2 Y390C mutation identified in high-risk Chinese breast cancer patients impairs its activity and is associated with increased breast cancer risk
N. Wang et al.
ONCOGENE (2015)
The de-ubiquitinase UCHL1 promotes gastric cancer metastasis via the Akt and Erk1/2 pathways
Yu-yu Gu et al.
TUMOR BIOLOGY (2015)
HTSeq-a Python framework to work with high-throughput sequencing data
Simon Anders et al.
BIOINFORMATICS (2015)
Upregulation of EGFR signaling is correlated with tumor stroma remodeling and tumor recurrence in FGFR1-driven breast cancer
Xue B. Holdman et al.
BREAST CANCER RESEARCH (2015)
Silencing of UCHL1 by CpG Promoter Hyper-methylation is Associated with Metastatic Gastroenteropancreatic Well-Differentiated Neuroendocrine (Carcinoid) Tumors
David A. Kleiman et al.
ANNALS OF SURGICAL ONCOLOGY (2014)
Role of Ki-67 Proliferation Index in the Assessment of Patients with Neuroendocrine Neoplasias Regarding the Stage of Disease
H. C. Miller et al.
WORLD JOURNAL OF SURGERY (2014)
voom: precision weights unlock linear model analysis tools for RNA-seq read counts
Charity W. Law et al.
GENOME BIOLOGY (2014)
Thyroid stimulating hormone increases iodine uptake by thyroid cancer cells during BRAF silencing
David A. Kleiman et al.
JOURNAL OF SURGICAL RESEARCH (2013)
Ubiquitin C-Terminal Hydrolase-L1 Potentiates Cancer Chemosensitivity by Stabilizing NOXA
Kerstin Brinkmann et al.
CELL REPORTS (2013)
Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks
Cole Trapnell et al.
NATURE PROTOCOLS (2012)
Deubiquitinases in cancer: new functions and therapeutic options
J. M. Fraile et al.
ONCOGENE (2012)
The Ubiquitin Peptidase UCHL1 Induces G0/G1 Cell Cycle Arrest and Apoptosis Through Stabilizing p53 and Is Frequently Silenced in Breast Cancer
Tingxiu Xiang et al.
PLOS ONE (2012)
The Epidemiology of Gastroenteropancreatic Neuroendocrine Tumors
Ben Lawrence et al.
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA (2011)
VEGFR-2 expression in carcinoid cancer cells and its role in tumor growth and metastasis
Scott R. Silva et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
A survey of methylated candidate tumor suppressor genes in nasopharyngeal carcinoma
Myriam Loyo et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Ubiquitin carboxyl-terminal hydrolase 1 (UCHL1) is a potential tumour suppressor in prostate cancer and is frequently silenced by promoter methylation
Ramesh Ummanni et al.
MOLECULAR CANCER (2011)
Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine Tumors.
Eric Raymond et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Everolimus for Advanced Pancreatic Neuroendocrine Tumors.
James C. Yao et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
DAXX/ATRX, MEN1, and mTOR Pathway Genes Are Frequently Altered in Pancreatic Neuroendocrine Tumors
Yuchen Jiao et al.
SCIENCE (2011)
Compensatory activation of Akt in response to mTOR and Raf inhibitors - A rationale for dual-targeted therapy approaches in neuroendocrine tumor disease
Kathrin Zitzmann et al.
CANCER LETTERS (2010)
The Tumor Suppressor UCHL1 Forms a Complex with p53/MDM2/ARF to Promote p53 Signaling and Is Frequently Silenced in Nasopharyngeal Carcinoma
Lili Li et al.
CLINICAL CANCER RESEARCH (2010)
Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation
Cole Trapnell et al.
NATURE BIOTECHNOLOGY (2010)
The Pathologic Classification of Neuroendocrine Tumors A Review of Nomenclature, Grading, and Staging Systems
David S. Klimstra et al.
PANCREAS (2010)
Pathway Biomarker Profiling of Localized and Metastatic Human Prostate Cancer Reveal Metastatic and Prognostic Signatures
Robert L. Grubb et al.
JOURNAL OF PROTEOME RESEARCH (2009)
Epigenetic control of the ubiquitin carboxyl terminal hydrolase 1 in renal cell carcinoma
Barbara Seliger et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2009)
Structure and Activation Mechanism of the CHK2 DNA Damage Checkpoint Kinase
Zhenjian Cai et al.
MOLECULAR CELL (2009)
Ubiquitin C-terminal hydrolase-L1 is a key regulator of tumor cell invasion and metastasis
H. J. Kim et al.
ONCOGENE (2009)
Pancreatic neuroendocrine tumors (PNETs): incidence, prognosis and recent trend toward improved survival
T. R. Halfdanarson et al.
ANNALS OF ONCOLOGY (2008)
Epigenetic identification of ubiquitin carboxyl-terminal hydrolase L1 as a functional tumor suppressor and biomarker for hepatocellular carcinoma and other digestive tumors
Jun Yu et al.
HEPATOLOGY (2008)
Human prostate cancer cells express neuroendocrine cell markers PGP 9.5 and chromogranin A
Aaron Leiblich et al.
PROSTATE (2007)
Silencing of the UCHL1 gene in human colorectal and ovarian cancers
Eriko Okochi-Takada et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
The ubiquitin-proteasome pathway and its role in cancer
A Mani et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
PGP9.5 promoter methylation is an independent prognostic factor for esophageal squamous cell carcinoma
DL Mandelker et al.
CANCER RESEARCH (2005)
DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis
J Bartkova et al.
NATURE (2005)
Chk2 kinase - A busy messenger
J Bartek et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2001)
DNA damage-induced activation of p53 by the checkpoint kinase Chk2
A Hirao et al.
SCIENCE (2000)
Share Paper
